All Announcements
Morrison & Foerster advises Endurance Acquisition Corp. on IPO
Morrison & Foerster represented Endurance Acquisition Corp. (NASDAQ: EDNCU), a special purpose acquisition company (SPAC) in its $200 million initial public offering.
Read MoreMorrison & Foerster advises DSP Group in sale to Synaptics
Morrison & Foerster advises DSP Group, Inc. (NASDAQ: DSPG) (“DSP Group”), a leading global provider of voice and wireless chipset solutions for converged communications, in connection with its sale to Synaptics Incorporated (NYSE: SYNA) (“Synaptics”), in an all cash deal for $22 per share.
Read MoreHogene Choi joins Morrison & Foerster as a partner in its patent strategy + prosecution group
Morrison & Foerster announces the arrival of Hogene Choi as a partner in its Patent Strategy + Prosecution Group. Ms. Choi brings over 20 years of combined experience in technical software engineering, data analytics, machine learning and artificial intelligence (AI), patent prosecution, and litigation to the firm.
Read MoreMorrison & Foerster advises Generate Capital in $2 billion fundraise for sustainable infrastructure investments and climate solutions
Morrison & Foerster advises Generate Capital, Inc. (“Generate”), a leading sustainable infrastructure company, in connection with its recently announced $2 billion fundraise from some of the world’s leading institutional investors to accelerate deployment of sustainable infrastructure.
Read MoreAnthony S. Fiotto joins Morrison & Foerster as head of their litigation department in Boston
Morrison & Foerster announces the addition of Anthony S. Fiotto to its Litigation Department in Boston, where he will serve as the office’s litigation head. Mr. Fiotto brings to the firm thirty years of broad litigation and arbitration experience, including extensive first chair trial experience.
Read MoreMorrison & Foerster advises OpenInvest in sale to J.P. Morgan
Morrison & Foerster advises OpenInvest, a leading financial technology company that helps financial professionals customize and report on values-based investments, in its sale to J.P. Morgan, a global leader in investment management and private banking.
Read MoreFormer FDA chief counsel Stacy Cline Amin joins Morrison & Foerster
Morrison & Foerster announces the arrival of Stacy Cline Amin as a partner in its Life Sciences + Healthcare practice. Ms. Amin will be based in Washington, D.C. and will co-lead the FDA Regulatory and Compliance practice.
Read More